**Core Concept**
Renal osteodystrophy is a term that encompasses a range of bone disorders associated with chronic kidney disease (CKD), particularly those involving secondary hyperparathyroidism. It results from the imbalance of calcium, phosphate, and vitamin D metabolism due to impaired renal function. This condition can lead to various bone-related complications, including osteomalacia, osteitis fibrosa cystica, and adynamic bone disease.

**Why the Correct Answer is Right**
Renal osteodystrophy is characterized by hyperparathyroidism, which is a result of the body's attempt to compensate for the low calcium levels caused by decreased renal production of active vitamin D (1,25-dihydroxyvitamin D). This leads to increased parathyroid hormone (PTH) levels, causing increased bone resorption and release of calcium into the bloodstream. Other features of renal osteodystrophy include **secondary hyperparathyroidism**, **osteomalacia**, **osteitis fibrosa cystica**, and **adynamic bone disease**.

**Why Each Wrong Option is Incorrect**
* **Option A:** Hyperparathyroidism is indeed a feature of renal osteodystrophy, so this option is incorrect.
* **Option C:** Osteomalacia is a characteristic of renal osteodystrophy, particularly in the early stages of CKD.
* **Option D:** Osteitis fibrosa cystica is a complication of prolonged secondary hyperparathyroidism, making it a feature of renal osteodystrophy.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that renal osteodystrophy is a dynamic condition that can change over time, and its management involves careful monitoring of calcium, phosphate, and PTH levels, as well as addressing any underlying CKD-related issues.

**Correct Answer:** B.